Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ALPHA INTERFERON, TUMOR INFILTRATING LYMPHOCYTES, AND INTERLEUKIN-2 IN THE TREATMENT OF CANCER

NCT00002733 is registered in ClinicalTrials.gov with Hoag Memorial Hospital Presbyterian as lead sponsor.

NCT NCT00002733
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ALPHA INTERFERON, TUMOR INFILTRATING LYMPHOCYTES, AND INTERLEUKIN-2 IN THE TREATMENT OF CANCER
Lead sponsor
Hoag Memorial Hospital Presbyterian
Phase
Phase 2
Overall status
Completed
Start date
January 31, 1996
Completion date
January 31, 2000
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney cancer, melanoma (skin), unspecified adult solid tumor, protocol specific